World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
Netherlands
2026
Award Badge
Genetics and Molecular Biology
Netherlands
2024

D-Index & Metrics

Molecular Biology

D-Index
152
Citations
77743
World Ranking
81
National Ranking
2

Piet Borst publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Piet Borst sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 513 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Piet Borst D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Piet Borst sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 152 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Netherlands Leader Award
  • 2025 - Research.com Molecular Biology in Netherlands Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Netherlands Leader Award
  • 2023 - Research.com Molecular Biology in Netherlands Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Netherlands Leader Award
  • 1995 - Fellow of the American Academy of Arts and Sciences
  • 1992 - Robert Koch Gold Medal
  • 1991 - Member of the National Academy of Sciences
  • 1989 - Member of Academia Europaea
  • 1986 - Fellow of the Royal Society, United Kingdom
  • 1984 - Paul Ehrlich and Ludwig Darmstaedter Prize
  • 1978 - Royal Netherlands Academy of Arts and Sciences
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Piet Borst is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research spans several fields, with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader areas, Borst's work addresses subfields such as Clinical Biochemistry, Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, and Oncology.

The scientist's research topics include Metabolism and Genetic Disorders, Mitochondrial Function and Pathology, Cancer, Hypoxia, and Metabolism, Drug Transport and Resistance Mechanisms, HIV/AIDS drug development and treatment, Trace Elements in Health, and Cardiovascular Function and Risk Factors.

Among frequent collaborators are Ben N. Schmermund, Andreas Rieth, Matthias Rademann, Steffen D. Kriechbaum, and Jan Sebastian Wolter.

Piet Borst has contributed to several peer-reviewed papers, including:

  • The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway, 2020, IUBMB Life
  • Looking back at multidrug resistance (MDR) research and ten mistakes to be avoided when writing about ABC transporters in MDR, 2020, FEBS Letters
  • Abnormal Left Atrial Strain by CMR Is Associated With Left Heart Disease in Patients With Pulmonary Hypertension, 2025, Circulation Heart Failure
  • Adventures With Parasites, Metabolism, Inborn Errors, and Cancer, 2023, JAMA

The venues in which Borst frequently publishes include:

  • IUBMB Life
  • FEBS Letters
  • Circulation Heart Failure
  • JAMA

Over the course of their career, Borst has received various recognitions and awards. These include election as a Fellow of the American Academy of Arts and Sciences in 1995, the Robert Koch Gold Medal in 1992, membership in the National Academy of Sciences in 1991, membership in Academia Europaea in 1989, and fellowship with the Royal Society in the United Kingdom since 1986.

Additional honors include the Paul Ehrlich and Ludwig Darmstaedter Prize awarded in 1984, election to the Royal Netherlands Academy of Arts and Sciences in 1978, and membership in the European Molecular Biology Organization (EMBO).

Best Publications

  • Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

    A.H. Schinkel;J.J.M. Smit;O. van Tellingen;J.H. Beijnen

  • A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins

    Piet Borst;Raymond Evers;Marcel Kool;Jan Wijnholds

  • Mammalian ABC Transporters in Health and Disease

    P. Borst;R.P.J. Oude Elferink

  • Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

    J.J.M. Smit;A.H. Schinkel;R.P.J.Oude Elferink;A.K. Groen

  • Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

    A. H. Schinkel;E. Wagenaar;L. Van Deemter;C. A. A. M. Mol

  • Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

    A. H. Schinkel;U. Mayer;E. Wagenaar;C. A. A. M. Mol

  • Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

    M. Kool;M. De Haas;G. L. Scheffer;R. J. Scheper

  • Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

    A. Sparreboom;J. van Asperen;U. Mayer;A.H. Schinkel

  • MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine

    Ardy van Helvoort;Alexander J Smith;Hein Sprong;Ingo Fritzsche

  • High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

    Sven Rottenberg;Janneke E. Jaspers;Ariena Kersbergen;Eline van der Burg

  • Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.

    Coen C. Paulusma;Piter J. Bosma;Guido J. R. Zaman;Conny T. M. Bakker

  • The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.

    G.J.R. Zaman;M.J. Flens;M.R. van Leusden;M. de Haas

  • The multidrug resistance protein family.

    Piet Borst;Raymond Evers;Marcel Kool;Jan Wijnholds

  • MRP3, an organic anion transporter able to transport anti-cancer drugs

    M. Kool;M. van der Linden;M. de Haas;G. L. Scheffer

  • Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport

    M. Muller;C. Meijer;G. J. R. Zaman;P. Borst

  • A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.

    C. C. Paulusma;M. Kool;P. J. Bosma;G. L. Scheffer

  • The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

    Glen Reid;Pieter Wielinga;Noam Zelcer;Ingrid van der Heijden

  • Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

    G J Zaman;J Lankelma;O van Tellingen;J Beijnen

  • Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

    R. Evers;M. Kool;L. Van Deemter;H. Janssen

  • Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

    J Wijnholds;C A Mol;L van Deemter;M de Haas

Frequent Co-Authors

Sven Rottenberg
Sven Rottenberg University of Bern
Alfred H. Schinkel
Alfred H. Schinkel Antoni van Leeuwenhoek Hospital
Jos Jonkers
Jos Jonkers Antoni van Leeuwenhoek Hospital
Jan Wijnholds
Jan Wijnholds Leiden University Medical Center
Paul A. M. Michels
Paul A. M. Michels University of Edinburgh
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Frank Baas
Frank Baas Leiden University Medical Center
Leslie A. Grivell
Leslie A. Grivell University of Amsterdam
Marina Pajic
Marina Pajic Garvan Institute of Medical Research
George L. Scheffer
George L. Scheffer VU University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Molecular Biology opens diverse career pathways, especially in the healthcare and life sciences sectors. Many professionals interested in transitioning to clinical or advanced nursing roles now consider online degree programs for flexibility and speed. Choosing the right program depends on your current credentials and long-term ambitions.

Prospective nurse practitioners typically wonder how many years does it take to be a nurse practitioner. The journey can vary, but accelerated options are available for those with previous science or nursing backgrounds. For registered nurses looking to advance quickly, the fastest rn to bsn program can offer a rapid path to higher qualifications within months.

Bridge options are also gaining popularity. Programs like rn to np bridge programs enable RNs to move straight toward a nurse practitioner career without earning an intermediate degree. For individuals without a nursing background but holding a bachelor’s in another field, direct entry msn programs offer a streamlined path to advanced nursing roles.

Ultimately, online degrees create more accessible opportunities for Molecular Biology graduates interested in expanding into healthcare careers.

Best Scientists Citing Piet Borst

Trending Scientists